Crinetics Pharmaceuticals (CRNX) Enterprise Value (2017 - 2026)
Crinetics Pharmaceuticals' quarterly Enterprise Value came in at -$1.3 billion in Q1 2026, down 1.35% year-on-year from -$1.3 billion in Q1 2025, and down 25.63% quarter-over-quarter from -$1.0 billion in Q4 2025.
Crinetics Pharmaceuticals has reported Enterprise Value for 10 years, with the latest figure at -$1.3 billion in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 1.35% year-over-year to -$1.3 billion; the trailing twelve-month figure through Mar 2026 stood at -$1.3 billion (down 1.35% YoY), and the FY2025 full-year result was -$1.0 billion, up 24.09% from the prior year.
- Enterprise Value for Q1 2026 stood at -$1.3 billion, down from -$1.0 billion in the prior quarter.
- The five-year high for Enterprise Value was -$34.6 million in Q4 2022, with the low at -$1.4 billion in Q4 2024.
- Average Enterprise Value over 5 years is -$672.7 million, with a median of -$862.7 million recorded in 2024.
- Year-over-year, Enterprise Value soared 86.91% in 2023 and plunged 2052.27% in 2024.
- Tracing CRNX's Enterprise Value over 5 years: stood at -$34.6 million in 2022, then plunged by 1512.41% to -$558.6 million in 2023, then sank by 142.42% to -$1.4 billion in 2024, then climbed by 24.09% to -$1.0 billion in 2025, then decreased by 25.63% to -$1.3 billion in 2026.
- The last three Enterprise Value figures came in at -$1.3 billion (Q1 2026), -$1.0 billion (Q4 2025), and -$1.1 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Crinetics Pharmaceuticals | 3.59 Bn | 3.59 Bn | 10.53 Mn | -1.29 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.29 Bn |
| Dec 31, 2025 | -1.03 Bn |
| Sep 30, 2025 | -1.09 Bn |
| Jun 30, 2025 | -1.20 Bn |
| Mar 31, 2025 | -1.27 Bn |
| Dec 31, 2024 | -1.35 Bn |
| Sep 30, 2024 | -862.67 Mn |
| Jun 30, 2024 | -862.95 Mn |
| Mar 31, 2024 | -900.96 Mn |
| Dec 31, 2023 | -558.56 Mn |
| Sep 30, 2023 | -142.80 Mn |
| Jun 30, 2023 | -40.22 Mn |
| Mar 31, 2023 | -41.86 Mn |
| Dec 31, 2022 | -34.64 Mn |
| Sep 30, 2022 | -368.36 Mn |
| Jun 30, 2022 | -62.39 Mn |
| Mar 31, 2022 | -319.73 Mn |
| Dec 31, 2021 | -201.26 Mn |
| Sep 30, 2021 | -193.33 Mn |
| Jun 30, 2021 | -203.76 Mn |
| Mar 31, 2021 | -150.67 Mn |
| Dec 31, 2020 | -170.88 Mn |
| Sep 30, 2020 | -186.82 Mn |
| Jun 30, 2020 | -205.17 Mn |
| Mar 31, 2020 | -112.80 Mn |
| Dec 31, 2019 | -118.39 Mn |
| Sep 30, 2019 | -131.67 Mn |
| Jun 30, 2019 | -230.26 Mn |
| Mar 31, 2019 | -157.21 Mn |
| Dec 31, 2018 | -163.88 Mn |
| Sep 30, 2018 | -169.65 Mn |
| Jun 30, 2018 | -68.41 Mn |
| Dec 31, 2017 | -14.19 Mn |